CONTACT US
Toll Free
4:00am - 8:00pm (M-F)
7:00am - 3:30pm (S/S)
(Pacific Standard Time)
CERTIFIED PHARMACY
Home | Prescription Drugs | Dermatop

Dermatop (Prenicarbate)

Type
Drug
Mfr.
Country
Dosage
Qty
Price(USD)
Type:
Drug:Dermatop Cream
Mfr.:Bausch Health
Country:Canada
Dosage:0.1 %/20 gm
Qty:1
Price:$91.99
Type:
Dermatop Cream
Bausch Health
Canada
0.1 %/60 gm
1
$151.99
Type:
Drug:Dermatop Ointment
Mfr.:Bausch Health
Country:Canada
Dosage:0.1 %/60 gm
Qty:1
Price:$151.99
Type:
Dermatop Ointment
Bausch Health
Canada
0.1 %/60 gm
2
$261.99
Type:
Drug:Dermatop Cream
Mfr.:Bausch Health
Country:Canada
Dosage:0.1 %/20 gm
Qty:2
Price:$131.99
Type:
Dermatop Cream
Bausch Health
Canada
0.1 %/60 gm
2
$261.99

Information

Dermatop (Prednicarbate) is a corticosteroid used to reduce the itching, redness, and swelling associated with many skin conditions. DERMATOP® Emollient Cream (prednicarbate emollient cream) 0.1% contains prednicarbate, a synthetic corticosteroid for topical dermatologic use.

DERMATOP Emollient Cream 0.1% is a medium-potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. DERMATOP Emollient Cream 0.1% may be used with caution in pediatric patients 1 year of age or older. The safety and efficacy of drug use for longer than 3 weeks in this population have not been established. Since safety and efficacy of DERMATOP Emollient Cream 0.1% have not been established in pediatric patients below 1 year of age, its use in this age group is not recommended. The use of DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1% is supported by results of a threeweek, uncontrolled study in 59 pediatric patients between the ages of 4 months and 12 years of age with atopic dermatitis. None of the 59 pediatric patients showed evidence of HPA-axis suppression. Safety and efficacy of DERMATOP Emollient Cream 0.1% in pediatric patients below 1 year of age have not been established, therefore use in this age group is not recommended. Because of a higher ratio of skin surface area to body mass, pediatric patients are at a greater risk than adults of HPA-axis suppression and Cushing's syndrome when they are treated with topical corticosteroids. They are therefore also at greater risk of adrenal insufficiency during and/or after withdrawal of treatment. In an uncontrolled study in pediatric patients with atopic dermatitis, the incidence of adverse reactions possibly or probably associated with the use of DERMATOP Emollient Cream 0.1% was limited.

Side Effects

CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience itching, burning, redness, or swelling. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website. canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, New Zealand, Australia, Turkey, Mauritius, India, and the United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with licensed pharmacies and fulfillment centers that procure products from reliable sources.